COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,672 Articles (22,913 medRxiv, 8,759 bioRxiv)

Most recent first Previous |  Page 1806: Articles 18051-18060  | Next

Emergent effects of contact tracing robustly stabilize outbreaks
Kotil, S. E.
10.1101/2021.02.25.21252445 — Posted: 2021-03-01
Predicting COVID-19 related death using the OpenSAFELY platform
Williamson, E. J., Tazare, J., Bhaskaran, K., McDonald, H. I., Walker, A. J., Tomlinson, L., Wing, K., Bacon, S., Bates, C., Curtis, H. J., Forbes, H., Minassian, C., Morton, C. E., Nightingale, E., Mehrkar, A., Evans, D., Nicholson, B. D., Leon, D., Inglesby, P., MacKenna, B., Davies, N. G., DeVito, N. J., Drysdale, H., Cockburn, J., Hulme, W. J., Morley, J., Douglas, I., Rentsch, C. T., Mathur, R., Wong, A., Schultze, A., Croker, R., Parry, J., Hester, F., Harper, S., Grieve, R., Harrison, D. A., Steyerberg, E. W., Eggo, R. M., Diaz-Ordaz, K., Keogh, R., Evans, S. J., Smeeth, L., Goldacre, B.
10.1101/2021.02.25.21252433 — Posted: 2021-03-01
Reanalysis of the Pfizer mRNA BNT162b2 SARS-CoV-2 vaccine data fails to find any increased efficacy following the boost: Implications for vaccination policy and our understanding of the mode of action
Saul, A., Drummer, H. E., Scott, N., Spelman, T., Crabb, B. S., Hellard, M.
10.1101/2021.02.23.21252315 — Posted: 2021-03-01
Consistency of performance of adverse outcome prediction models for hospitalized COVID-19 patients
Castro, V. M., McCoy, T. H., Perlis, R. H.
10.1101/2021.02.25.21252410 — Posted: 2021-03-01
Genetics of symptom remission in outpatients with COVID-19
Dube, M.-P., Lemacon, A., Barhdadi, A., Lemieux Perreault, L.-P., Oussaid, E., Asselin, G., Provost, S., Sun, M., Sandoval, J., Legault, M.-A., Mongrain, I., Dubois, A., Valois, D., Dedelis, E., Lousky, J., Choi, J., Goulet, E., Savard, C., Chicoine, L.-M., Cossette, M., Chabot-Blanchet, M., Guertin, M.-C., de Denus, S., Bouabdallaoui, N., Marchand, R., Bassevitch, Z., Nozza, A., Gaudet, D., L'Allier, P. L., Hussin, J., Boivin, G., Busseuil, D., Tardif, J.-C.
10.1101/2021.02.24.21252396 — Posted: 2021-03-01
Multi-objective Risk-based Resource Allocation for Urban Pandemic Preparedness: The COVID-19 Case in Bogota, Colombia
Prieto, J., Gomez, J.
10.1101/2021.02.24.21252407 — Posted: 2021-03-01
A novel 5E training model and other methods implemented for rapid readiness at an ad-hoc COVID-19 facility in India
Singh, S., Singh, A. R., Pathak, B., Tilak, T., Kumar, A., Bhatia, I., Hasvi, J.
10.1101/2021.02.23.21251976 — Posted: 2021-03-01
COVID-19 Vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-methods study
Dereje, N., Tesfaye, A., Tamene, B., Alemshet, D., Abe, H., Tesfa, N., Gedion, S., Biruk, T., Lakew, Y.
10.1101/2021.02.25.21252443 — Posted: 2021-03-01
HYPER: Group testing via hypergraph factorization applied to COVID-19
Hong, D., Dey, R., Lin, X., Cleary, B., Dobriban, E.
10.1101/2021.02.24.21252394 — Posted: 2021-03-01
Graphical Models of Pandemic
Chertkov, M., Abrams, R., Esmaieeli Sikaroudi, A. M., Krechetov, M., Slagle, C. N., Efrat, A., Fulek, R., Oren, E.
10.1101/2021.02.24.21252390 — Posted: 2021-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).